![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » Casmed’s OEM Version of Tissue Oximeter Cleared by FDA
Casmed’s OEM Version of Tissue Oximeter Cleared by FDA
![ClearanceStamp_Gray.gif](https://www.fdanews.com/ext/resources/test/Device_Images6/ClearanceStamp_Gray.gif?t=1576043982&width=430)
May 16, 2018
The FDA approved Casmed’s original equipment manufacturer version of its Fore-Sight Elite tissue oximeter.
The device displays tissue oximetry values on a third party manufactured monitor through a Fore-Sight technology cable connected to sensors on the patient’s forehead.
The device is designed for minimal user-interface modifications for use with third party monitors.
Upcoming Events
-
21Oct